December 14, 2017
An 8-week course of Harvoni for hepatitis C virus infection in both black and nonblack patients was a cost-effective alternative to a 12-week course, according to researchers.
Shorter course therapy may be a viable option under a constrained budget and can benefit patients who are treatment-naive and noncirrhotic, they wrote in Open Forum Infectious Diseases.
Continue reading: https://www.healio.com/infectious-disease/hepatitis-c/news/in-the-journals/%7B0ad54f9e-eabf-4be3-9d1e-5cfdf2513ba1%7D/8-week-harvoni-cost-effective-alternative-to-12-week-regimen
Shorter course therapy may be a viable option under a constrained budget and can benefit patients who are treatment-naive and noncirrhotic, they wrote in Open Forum Infectious Diseases.
Continue reading: https://www.healio.com/infectious-disease/hepatitis-c/news/in-the-journals/%7B0ad54f9e-eabf-4be3-9d1e-5cfdf2513ba1%7D/8-week-harvoni-cost-effective-alternative-to-12-week-regimen
SVR after HCV treatment improves liver stiffness in progressive fibrosis
December 14, 2017
Sustained virologic response after direct-acting antiviral treatment for hepatitis C significantly improved liver stiffness from baseline to end of treatment, and…
Continue reading: https://www.healio.com/hepatology/hepatitis-c/news/online/%7Bbbe95f7d-0dac-4db6-a05e-ccfe72d878e0%7D/svr-after-hcv-treatment-improves-liver-stiffness-in-progressive-fibrosis
No comments:
Post a Comment